ArticleJournal of clinical medicine2022

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis.

Binyao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.